News-Blog

Current news and articles

Adherex Reports Recent Developments and Second Quarter June 30, 2013 Financial Results

By admin Final data from Phase III STS Trial Expected in Q3 2013 Company to Focus on Development of Sodium Thiosulfate (STS) for Prevention of Hearing Loss in Pediatric Oncology Patients Possibility of Commercial Partnership for Eniluracil (EU) will be explored Research Triangle Park, NC, August 09, 2013 – – Adherex Technologies Inc. (TSX:AHX, OTCQB:

Adherex Reports Recent Developments and Second Quarter June 30, 2013 Financial Results Read More »

Scroll to Top